Older adults with colon cancer are not different from younger ones, but treated differently: Retrospective analysis from single centre.
Merve Güner OytunGülcan BulutErhan GökmenBurcu B DoğuBülent KarabulutPublished in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Geriatric people are underrepresented in clinical trials,because of the presence of the limitations in the older patients. The results of our study revealed older patients with colon cancer patients underwent surgery less than the younger ones, they recieved monotherapy more frequently as first-line chemotherapy, and less frequently targeted therapy. Their mortality was higher. It was shown that decision-making of colon cancer therapy is influenced by age according to our results.
Keyphrases
- cancer therapy
- clinical trial
- decision making
- physical activity
- minimally invasive
- coronary artery bypass
- drug delivery
- open label
- cardiovascular events
- locally advanced
- combination therapy
- randomized controlled trial
- single cell
- radiation therapy
- middle aged
- risk factors
- acute coronary syndrome
- phase ii
- hip fracture
- cardiovascular disease